Name | Number of supported studies | Average coverage | |
---|---|---|---|
non-classical monocyte | 17 studies | 35% ± 14% | |
macrophage | 7 studies | 25% ± 10% | |
classical monocyte | 6 studies | 24% ± 9% | |
endothelial cell | 5 studies | 19% ± 3% | |
conventional dendritic cell | 4 studies | 30% ± 10% | |
smooth muscle cell | 4 studies | 23% ± 4% | |
pericyte | 3 studies | 19% ± 4% | |
dendritic cell | 3 studies | 27% ± 13% | |
intermediate monocyte | 3 studies | 27% ± 8% | |
fibroblast | 3 studies | 24% ± 6% | |
monocyte | 3 studies | 19% ± 3% |
Insufficient scRNA-seq data for expression of CAMK1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 1991.16 | 245 / 245 | 99% | 5.93 | 498 / 502 |
brain | 98% | 2405.17 | 2602 / 2642 | 99% | 4.99 | 701 / 705 |
kidney | 100% | 1345.79 | 89 / 89 | 90% | 3.06 | 813 / 901 |
ovary | 100% | 2260.49 | 180 / 180 | 89% | 2.41 | 384 / 430 |
thymus | 100% | 1319.24 | 651 / 653 | 87% | 2.48 | 526 / 605 |
liver | 100% | 1148.91 | 226 / 226 | 85% | 1.99 | 345 / 406 |
adrenal gland | 100% | 5516.53 | 258 / 258 | 84% | 3.11 | 194 / 230 |
stomach | 93% | 1090.52 | 335 / 359 | 85% | 2.13 | 243 / 286 |
intestine | 99% | 1493.09 | 956 / 966 | 78% | 1.69 | 409 / 527 |
lung | 100% | 1470.06 | 576 / 578 | 70% | 1.37 | 814 / 1155 |
breast | 100% | 2265.41 | 459 / 459 | 64% | 1.10 | 718 / 1118 |
bladder | 100% | 1657.43 | 21 / 21 | 57% | 1.30 | 285 / 504 |
uterus | 99% | 2057.91 | 169 / 170 | 53% | 1.33 | 241 / 459 |
esophagus | 86% | 1484.13 | 1246 / 1445 | 58% | 1.04 | 107 / 183 |
skin | 75% | 572.94 | 1362 / 1809 | 60% | 1.31 | 285 / 472 |
pancreas | 40% | 188.80 | 131 / 328 | 76% | 1.37 | 135 / 178 |
adipose | 100% | 2757.28 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2145.07 | 1334 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 998.80 | 240 / 241 | 0% | 0 | 0 / 0 |
heart | 96% | 718.61 | 824 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 75% | 752.93 | 695 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 66% | 1.78 | 19 / 29 |
tonsil | 0% | 0 | 0 / 0 | 42% | 0.63 | 19 / 45 |
eye | 0% | 0 | 0 / 0 | 39% | 0.55 | 31 / 80 |
muscle | 14% | 61.68 | 111 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0018105 | Biological process | peptidyl-serine phosphorylation |
GO_0010976 | Biological process | positive regulation of neuron projection development |
GO_0051147 | Biological process | regulation of muscle cell differentiation |
GO_0007165 | Biological process | signal transduction |
GO_0032880 | Biological process | regulation of protein localization |
GO_0051149 | Biological process | positive regulation of muscle cell differentiation |
GO_0046827 | Biological process | positive regulation of protein export from nucleus |
GO_0043393 | Biological process | regulation of protein binding |
GO_0060143 | Biological process | positive regulation of syncytium formation by plasma membrane fusion |
GO_0051835 | Biological process | positive regulation of synapse structural plasticity |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0030154 | Biological process | cell differentiation |
GO_0060999 | Biological process | positive regulation of dendritic spine development |
GO_0006913 | Biological process | nucleocytoplasmic transport |
GO_0006468 | Biological process | protein phosphorylation |
GO_0032091 | Biological process | negative regulation of protein binding |
GO_0071902 | Biological process | positive regulation of protein serine/threonine kinase activity |
GO_0007399 | Biological process | nervous system development |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005622 | Cellular component | intracellular anatomical structure |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0004683 | Molecular function | calmodulin-dependent protein kinase activity |
GO_0005516 | Molecular function | calmodulin binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CAMK1 |
Protein name | Calcium/calmodulin-dependent protein kinase type 1 (EC 2.7.11.17) (CaM kinase I) (CaM-KI) (CaM kinase I alpha) (CaMKI-alpha) Calcium/calmodulin dependent protein kinase I Calcium/calmodulin-dependent protein kinase I, isoform CRA_a (Calcium/calmodulin-dependent protein kinase type 1) (cDNA, FLJ95825, Homo sapiens calcium/calmodulin-dependent protein kinase I (CAMK1),mRNA) Calcium/calmodulin-dependent protein kinase I |
Synonyms | hCG_21548 |
Description | FUNCTION: Calcium/calmodulin-dependent protein kinase that operates in the calcium-triggered CaMKK-CaMK1 signaling cascade and, upon calcium influx, regulates transcription activators activity, cell cycle, hormone production, cell differentiation, actin filament organization and neurite outgrowth. Recognizes the substrate consensus sequence [MVLIF]-x-R-x(2)-[ST]-x(3)-[MVLIF]. Regulates axonal extension and growth cone motility in hippocampal and cerebellar nerve cells. Upon NMDA receptor-mediated Ca(2+) elevation, promotes dendritic growth in hippocampal neurons and is essential in synapses for full long-term potentiation (LTP) and ERK2-dependent translational activation. Downstream of NMDA receptors, promotes the formation of spines and synapses in hippocampal neurons by phosphorylating ARHGEF7/BETAPIX on 'Ser-694', which results in the enhancement of ARHGEF7 activity and activation of RAC1. Promotes neuronal differentiation and neurite outgrowth by activation and phosphorylation of MARK2 on 'Ser-91', 'Ser-92', 'Ser-93' and 'Ser-294'. Promotes nuclear export of HDAC5 and binding to 14-3-3 by phosphorylation of 'Ser-259' and 'Ser-498' in the regulation of muscle cell differentiation. Regulates NUMB-mediated endocytosis by phosphorylation of NUMB on 'Ser-276' and 'Ser-295'. Involved in the regulation of basal and estrogen-stimulated migration of medulloblastoma cells through ARHGEF7/BETAPIX phosphorylation (By similarity). Is required for proper activation of cyclin-D1/CDK4 complex during G1 progression in diploid fibroblasts. Plays a role in K(+) and ANG2-mediated regulation of the aldosterone synthase (CYP11B2) to produce aldosterone in the adrenal cortex. Phosphorylates EIF4G3/eIF4GII. In vitro phosphorylates CREB1, ATF1, CFTR, MYL9 and SYN1/synapsin I. . |
Accessions | F8W6S9 H7C071 ENST00000397277.6 ENST00000256460.8 Q14012 C9JES6 ENST00000421120.1 ENST00000411972.1 B5BU41 B0YIY3 |